老年合并衰弱高血压患者的管理
Management of the Elderly Patients with Frailty Hypertension
DOI: 10.12677/ACM.2023.131020, PDF,   
作者: 米登洋, 李桂琼*：重庆医科大学附属第二医院，重庆
关键词: 老年人；高血压；衰弱；Elderly； Hypertension； Frailty
摘要: 高血压合并衰弱的老年患者在我国逐年增多，导致老年人发生不良结局的风险增高，因此积极控制高血压，能帮助减少心脑血管等事件的发生。但目前相关高血压指南对于此类高血压患者的管理目标值，暂未给出明确指导。综合相关文献指南，本文就老年衰弱患者的高血压管理进行综述。
Abstract: The number of the elderly patients with hypertension and frailty is increasing year by year in China, leading to an increased risk of adverse outcomes for the elderly. Therefore, active control of hyper-tension can help reduce the incidence of cardiovascular and cerebrovascular events. However, the current hypertension guidelines do not give clear guidance on the management target value of such hypertension patients. This article reviews the management of hypertension in elderly frailty pa-tients based on relevant literature guidelines.
文章引用：米登洋, 李桂琼. 老年合并衰弱高血压患者的管理[J]. 临床医学进展, 2023, 13(1): 128-133. https://doi.org/10.12677/ACM.2023.131020

参考文献

[1] 马丽媛, 王增武, 樊静, 胡盛寿. 《中国心血管健康与疾病报告2021》关于中国高血压流行和防治现状[J]. 中国全科医学, 2022, 25(30): 3715-3720. [Google Scholar] [CrossRef] 
[2] 中国老年医学学会高血压分会, 国家老年疾病临床医学研究中心中国老年心血管病防治联盟. 中国老年高血压管理指南2019[J]. 中国心血管杂志, 2019, 24(1): 1-23. [Google Scholar] [CrossRef] 
[3] 邹文淑, 王剑峰, 周莉华, 陈霞, 卿秀, 周从良. 老年单纯收缩期高血压的诊治进展[J]. 中华老年心脑血管病杂志, 2014, 16(12): 1343-1344. [Google Scholar] [CrossRef] 
[4] 中华医学会老年医学分会, 中国医师协会高血压专业委员会. 老年人高血压特点与临床诊治流程专家建议[J]. 中华老年医学杂志, 2014, 33(7): 689-701. [Google Scholar] [CrossRef] 
[5] 袁艳敏, 郭艺芳. 人体血压昼夜节律特征及其调节机制[J]. 中华高血压杂志, 2008, 16(6): 483-485. [Google Scholar] [CrossRef] 
[6] 胡亦新, 范利. 老年高血压合并衰弱的临床研究和管理进展——《中国老年高血压管理指南2019》解读[J]. 中华高血压杂志, 2019, 27(10): 910-913.
[7] Dent, E., Martin, F.C., Bergman, H., et al. (2019) Management of Frailty: Opportunities, Challenges, and Future Directions. The Lancet, 394, 1376-1386. [Google Scholar] [CrossRef] 
[8] 付梦雪, 张先庚. 老年人衰弱综合征的研究进展[J]. 护理研究, 2019, 33(17): 2973-2976. [Google Scholar] [CrossRef] 
[9] 马丽娜. 老年衰弱综合征的发病机制[J]. 中华老年医学杂志, 2021, 40(3): 379-382. [Google Scholar] [CrossRef] 
[10] 宁晓暄, 欧阳敏, Leng Sean X. 老年人衰弱综合征的发病机制和评估及管理[J]. 中华老年医学杂志, 2015, 34(12): 1282-1285. [Google Scholar] [CrossRef] 
[11] Leng, S.X., Cappola, A.R., Andersen, R.E., et al. (2004) Serum Levels of Insulin-Like Growth Factor-I (IGF-I) and Dehydroepiandrosterone Sulfate (DHEA-S), and Their Relationships with Serum Interleukin-6, in the Geriatric Syndrome of Frailty. Aging Clinical and Experimental Re-search, 16, 153-157. [Google Scholar] [CrossRef] 
[12] Pansarasa, O., Pistono, C., Davin, A., et al. (2019) Altered Immune System in Frailty: Genetics and Diet May Influence Inflammation. Ageing Research Reviews, 54, Article ID: 100935. [Google Scholar] [CrossRef] [PubMed]
[13] Clegg, A., Young, J., Iliffe, S., et al. (2013) Frailty in Elderly People. The Lancet, 381, 752-762. [Google Scholar] [CrossRef] 
[14] Marcos-Pérez, D., Sánchez-Flores, M., Maseda, A., et al. (2019) Serum Cortisol but Not Oxidative Stress Biomarkers Are Related to Frailty: Results of a Cross-Sectional Study in Spanish Older Adults. Journal of Toxicology and Environmental Health, Part A, 82, 815-825. [Google Scholar] [CrossRef] [PubMed]
[15] 尹佳慧, 曾雁冰, 周鼒, 方亚. 中国老年人衰弱状况及其影响因素分析[J]. 中华流病学杂志, 2018, 39(9): 1244- 1248. [Google Scholar] [CrossRef] [PubMed]
[16] Fried, L.P., Tangen, C.M., Walston, J., et al. (2001) Frailty in Older Adults: Evidence for a Phenotype. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 56, M146-M156. [Google Scholar] [CrossRef] 
[17] 韩君, 王君俏, 谢博钦, 王悦. Fried衰弱表型和FRAIL量表及埃德蒙顿衰弱评估量表在社区高龄老年人衰弱筛查中一致性和适用性的比较研究[J]. 中国全科医学, 2021, 24(21): 2669-2675. [Google Scholar] [CrossRef] 
[18] Mitnitski, A.B., Mogilner, A.J., Rockwood, K. (2001) Accumulation of Deficits as a Proxy Measure of Aging. Scientific World Journal, 1, 323-336. [Google Scholar] [CrossRef] [PubMed]
[19] Fan, J., Yu, C., Guo, Y., et al. (2020) Frailty Index and All-Cause and Cause-Specific Mortality in Chinese Adults: A Prospective Cohort Study. The Lancet Public Health, 5, e650-e660. [Google Scholar] [CrossRef] 
[20] 董冰茹, 顾杰. 社区老年人衰弱评估方法的研究进展[J]. 中国全科医学, 2021, 24(10): 1302-1308. [Google Scholar] [CrossRef] 
[21] Carmo Correia de Lima, M., Loffredo Bilton, T., Jef-ferson de Sousa Soares, W., et al. (2019) Maximum Walking Speed Can Improve the Diagnostic Value of Frailty among Community-Dwelling Older Adults: A Cross-Sectional Study. The Journal of Frailty & Aging, 8, 39-41. [Google Scholar] [CrossRef] [PubMed]
[22] Rolfson, D.B., Majumdar, S.R., Tsuyuki, R.T., et al. (2006) Validity and Reliability of the Edmonton Frail Scale. Age Ageing, 35, 526-529. [Google Scholar] [CrossRef] [PubMed]
[23] 中华医学会老年医学分会, 《中华老年医学杂志》编辑委员会. 老年人衰弱预防中国专家共识(2022) [J]. 中华老年医学杂志, 2022, 41(5): 503-511. [Google Scholar] [CrossRef] 
[24] Yao, S., Zheng, P., Ji, L., et al. (2020) The Effect of Comprehensive Assessment and Multi-Disciplinary Management for the Geriatric and Frail Patient: A Multi-Center, Randomized, Parallel Controlled Trial. Medicine (Baltimore), 99, e22873. [Google Scholar] [CrossRef] 
[25] Ruiz, J.G., Dent, E., Morley, J.E., et al. (2020) Screening for and Managing the Person with Frailty in Primary Care: ICFSR Consensus Guidelines. Journal of Nutrition, Health and Aging, 24, 920-927. [Google Scholar] [CrossRef] [PubMed]
[26] Zhang, Y., Zhang, Y., Li, Y., et al. (2020) Reliability and Validity of the Self-Reported Frailty Screening Questionnaire in Older Adults. Therapeutic Advances in Chronic Disease, 11. [Google Scholar] [CrossRef] [PubMed]
[27] Shang, N., Liu, H., Wang, N., et al. (2022) Comparison of Three Frailty Screening Instruments for Prediction of Adverse Outcomes among Older Adults in the Emergency Department. Geriatrics & Gerontology International, 22, 851-856. [Google Scholar] [CrossRef] [PubMed]
[28] Ma, L., Tang, Z., Chan, P. and Walston, J.D. (2019) Novel Frailty Screen-ing Questionnaire (FSQ) Predicts 8-Year Mortality in Older Adults in China. The Journal of Frailty & Aging, 8, 33-38. [Google Scholar] [CrossRef] [PubMed]
[29] Kang, M.G., Kim, S.W., Yoon, S.J., et al. (2017) Association between Frailty and Hypertension Prevalence, Treatment, and Control in the Elderly Korean Population. Scientific Reports, 7, Arti-cle No. 7542. [Google Scholar] [CrossRef] [PubMed]
[30] 范利, 李建华, 胡亦新, 王蓉, 赵婷, 库洪安, 杨雪, 李银艺, 张曼秀. 合并不同并发症的老年高血压患者的衰弱检出率[J]. 中华高血压杂志, 2015, 23(12): 1151-1155.
[31] 谭修竹, 冯静, 王志敏, 骆沁, 唐玺, 姚可茹, 尹心红. 社区高血压患者衰弱现状及其影响因素[J]. 医学信息, 2022, 35(3): 139-142. [Google Scholar] [CrossRef] 
[32] Warwick, J., Falaschetti, E., Rockwood, K., et al. (2015) No Evidence That Frailty Modifies the Positive Impact of Antihypertensive Treatment in Very Elderly People: An Investigation of the Impact of Frailty upon Treatment Effect in the Hypertension in the Very El-derly Trial (HYVET) Study, a Double-Blind, Placebo-Controlled Study of Antihypertensives in People with Hyperten-sion Aged 80 and over. BMC Medicine, 13, 78. [Google Scholar] [CrossRef] [PubMed]
[33] SPRINT Research Group, Wright, J.T., Williamson, J.D., et al. (2015) A Randomized Trial of Intensive versus Standard Blood-Pressure Control. The New England Journal of Medicine, 373, 2103-2116. [Google Scholar] [CrossRef] 
[34] Whelton, P.K., Carey, R.M., Aronow, W.S., et al. (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiolo-gy/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71, e13-e115. [Google Scholar] [CrossRef] 
[35] Williams, B., Mancia, G., Spiering, W., et al. (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. European Heart Journal, 39, 3021-3104. [Google Scholar] [CrossRef] [PubMed]
[36] Unger, T., Borghi, C., Charchar, F., et al. (2020) 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 75, 1334-1357. [Google Scholar] [CrossRef] 

为你推荐